Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
Keyword(s):
Keyword(s):
2018 ◽
Vol 149
(6)
◽
pp. 635-644
◽
Keyword(s):